Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer
Authors
Keywords
-
Journal
BMC CANCER
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2010-09-17
DOI
10.1186/1471-2407-10-496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer
- (2015) Geetha Srikrishna et al. NEOPLASIA
- Effector Memory T Lymphocytes Can Express Fc RIIIa and Mediate Antibody-Dependent Cellular Cytotoxicity
- (2014) B. Clemenceau et al. JOURNAL OF IMMUNOLOGY
- HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
- (2014) Y. Sha et al. JOURNAL OF IMMUNOLOGY
- HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer
- (2010) Yukiko Moriwaka et al. PATHOBIOLOGY
- Immunogenic cell death modalities and their impact on cancer treatment
- (2009) Oliver Kepp et al. APOPTOSIS
- A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
- (2009) Oliver F Bathe et al. BMC CANCER
- A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer
- (2009) Justin M Balko et al. BMC CANCER
- The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack
- (2009) Robert H Fletcher BMC Medicine
- Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
- (2009) M. Camus et al. CANCER RESEARCH
- HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer
- (2009) Yi Luo et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury
- (2009) Jon Cardinal et al. HEPATOLOGY
- Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
- (2009) Xingjun Yao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers
- (2009) Hyun Ju Kang et al. LABORATORY INVESTIGATION
- Suppression of Dendritic Cells by HMGB1 Is Associated with Lymph Node Metastasis of Human Colon Cancer
- (2009) Akiko Kusume et al. PATHOBIOLOGY
- Detection and Functional Analysis of Tumor Infiltrating T-Lymphocytes (TIL) in Liver Metastases from Colorectal Cancer
- (2008) Philipp Wagner et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overexpression of High Mobility Group (HMG) B1 and B2 Proteins Directly Correlates with the Progression of Squamous Cell Carcinoma in Skin
- (2008) Ashok Sharma et al. CANCER INVESTIGATION
- Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)
- (2008) P. Correale et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy
- (2008) M. Morris et al. CLINICAL CANCER RESEARCH
- Local Recurrence in Mismatch Repair-Proficient Colon Cancer Predicted by an Infiltrative Tumor Border and Lack of CD8+ Tumor-Infiltrating Lymphocytes
- (2008) I. Zlobec et al. CLINICAL CANCER RESEARCH
- Immunogenic anti-cancer chemotherapy as an emerging concept
- (2008) Nicole M Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- HMGB1: a two-headed signal regulating tumor progression and immunity
- (2008) Lara Campana et al. CURRENT OPINION IN IMMUNOLOGY
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- The immunogenicity of tumor cell death
- (2008) Oliver Kepp et al. CURRENT OPINION IN ONCOLOGY
- Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies
- (2008) Imke Atreya et al. Expert Review of Anticancer Therapy
- Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
- (2008) Hirotaka Kazama et al. IMMUNITY
- E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release
- (2008) Tegest Aychek et al. INTERNATIONAL JOURNAL OF CANCER
- The essential role of the in situ immune reaction in human colorectal cancer
- (2008) Franck Pagès et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma
- (2008) D Wu et al. JOURNAL OF PATHOLOGY
- Unknown
- (2008) John Klune et al. MOLECULAR MEDICINE
- Memory CD8 T-cell compartment grows in size with immunological experience
- (2008) Vaiva Vezys et al. NATURE
- Immunogenicity of anthracyclines: moving towards more personalized medicine
- (2008) Lionel Apetoh et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now